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Abstract
The amide moiety of peptides can be replaced for example by a triazole moiety, which is considered to be bioisosteric. Therefore,
the carbonyl moiety of an amino acid has to be replaced by an alkyne in order to provide a precursor of such peptidomimetics. As
most amino acids have a chiral center at Cα, such amide bond surrogates need a chiral moiety. Here the asymmetric synthesis of a
set of 24 N-sulfinyl propargylamines is presented. The condensation of various aldehydes with Ellman’s chiral sulfinamide provides
chiral N-sulfinylimines, which were reacted with (trimethylsilyl)ethynyllithium to afford diastereomerically pure N-sulfinyl
propargylamines. Diverse functional groups present in the propargylic position resemble the side chain present at the Cα of amino
acids. Whereas propargylamines with (cyclo)alkyl substituents can be prepared in a direct manner, residues with polar functional
groups require suitable protective groups. The presence of particular functional groups in the side chain in some cases leads to
remarkable side reactions of the alkyne moiety. Thus, electron-withdrawing substituents in the Cα-position facilitate a base induced
rearrangement to α,β-unsaturated imines, while azide-substituted propargylamines form triazoles under surprisingly mild condi-
tions. A panel of propargylamines bearing fluoro or chloro substituents, polar functional groups, or basic and acidic functional
groups is accessible for the use as precursors of peptidomimetics.
Introduction
Terminal alkynes display an intriguing versatility as building
blocks in organic and medicinal chemistry, as their reactivity is
unique. Their chemistry involves several highly selective reac-
tions, e.g., [3 + 2] cycloadditions with azides and isoelectronic
functional groups (among them the copper or ruthenium-cata-
lyzed azide–alkyne cycloaddition, CuAAC and RuAAC), the
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Figure 1: Concept of carboxylic acid or amide bond replacement on the basis of an alkyne moiety.
Figure 2: Selection of reactions based on propargylamines as precursors. a) Intramolecular Pauson–Khand reaction, R = (S)-tert-butylsulfinyl,
R’ = CH2CH2OTBDPS [14]. b) Diels–Alder reaction, R = pTs, R’ = H, R’’ = Me [15]. c) Gold-catalyzed intramolecular reaction to azetidin-3-ones,
R = tert-butylsulfonyl, R’ = aromatics, aliphatics [16]. d) Sonogashira cross-coupling, R = tert-butylsulfinyl, R’ = Me, CHMe2, CH2CHMe2, cyclohexyl
[17]. e,f) CuI or RuII-catalyzed [3 + 2] cycloadditions (CuAAC, RuAAC) [18-21]. e) R = Boc, R’ = Bn [19]. f) R = Boc, R’ = Me, CHMe2, CH2CHMe2,
R’’ = Me, CHMe2, CH2Ph [21].
thiol–yne reaction, Diels–Alder reactions and the Sonogashira
cross-coupling. While amino acids with a terminal alkyne in the
side chain are well-known, the synthesis of their correlates
where the carboxy group is replaced by a terminal alkyne is still
tedious. Nevertheless, these propargylamines have been
frequently used as precursors for the synthesis of diverse bioac-
tive compounds. Their conversion into triazoles is best investi-
gated, since triazoles as amide bond surrogates are found in
several inhibitors of proteases such as cathepsin S [1-6],
cysteine proteases [7], cruzain 20 [8,9], caspases [10] and
peptidyl aminopeptidases [11]. These protease inhibitors show
potential for the treatment of Chagas disease [2,9], Huntington’s
disease [10], malaria [11], autoimmune diseases [6] and the
imaging of tumor associated macrophages [2]. Whereas the
carboxylic acid function of amino acids can be easily converted
into amides or esters (Figure 1), propargylamines have been
converted into acids, alcohols [12] or olefins in order to obtain
natural products like angustureine and cuspareine [13].
Intramolecular Pauson–Khand reaction [14], Diels–Alder reac-
tion [15], gold-catalyzed azetidin-3-one formation [16], as well
as various transition metal-mediated additions and cross-coup-
ling reactions [17] represent further important reactions of
propargylamines, providing the potential to form innovative
peptidomimetics (Figure 2).
Our attention has been focused on the synthesis of amino acid
analogous propargylamines, furnished with Cα-substituents
imitating various amino acid side chains.
The direct conversion of amino acids into propargylamines by
the Corey–Fuchs or the Seyferth–Gilbert homologation has
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Figure 3: Two different approaches for the stereoselective de novo synthesis of propargylamines using Ellman’s chiral sulfinamide. (a) tert-Butyl
sulfinamide, Lewis acid, CH2Cl2. (b) Organometallic compound. (c) (Trimethylsilyl)ethynyllithium.
been successfully used for the preparation of several natural
amino acid analogues [22,23]. However, epimerization in the
α-position frequently occurs under the alkaline reaction condi-
tions of the Seyferth–Gilbert and the Corey–Fuchs reaction. In
order to access propargylamines with modified side chains, we
chose a de novo synthesis strategy, using Ellman’s chiral sulfin-
amide auxiliary to produce diastereomerically pure amines [7].
Ellman’s chiral sulfinamide can be readily synthesized on a lab-
oratory scale [24]. Moreover, sulfinamides can be cleaved
easily under acidic conditions [1,25,26] and the produced
sulfinic acid can even be recycled [25,27]. However, the sulfin-
amide auxiliary has to be treated with care, as it tends to dispro-
portionate quickly in solution at elevated temperature or in
chloroform at room temperature [28]. Furthermore, sulfin-
amides are unstable upon sonication [28]. Sulfinamides are also
reported to decompose in the presence of low concentrations of
acid under pressure, typical conditions of HPLC analysis.
Consequently, the application of the tert-butylsulfinyl as protec-
tive group for the amine is restricted to very mild conditions.
However, it can be easily cleaved from N-sulfinyl propargyl-
amines by acidic methanolysis and subsequent Boc protection
[21]. Here we report on the diastereoselective synthesis of chiral
N-sulfinyl propargylamines with amino acid type “side chains”
attached to the propargylic position mediated by Ellman’s auxil-
iary.
Enantiomerically pure amines can be obtained by condensation
of aldehydes or ketones with Ellman’s chiral sulfinamide, medi-
ated by KHSO4 [29], Cs2CO3 [30], Ti(OEt)4 [31-33], or CuSO4
[34], followed by either reduction [35-40] or addition of a
nucleophile to the imine [41]. In general, there are two options
(Figure 3) for the synthesis of enantiomerically pure propargyl-
amines by nucleophilic addition. The synthesis of propargyl-
amines by diastereoselective reductive amination requires
alkynyl ketones, which are difficult to prepare and are unstable
towards reductive conditions.
In approach I, organometallic nucleophiles are added to
N-sulfinyl propargylimines, derived from aldehydes. According
to approach II, a metallated terminal alkyne is added to an
N-sulfinylaldimine. In approach I, the organometallic nucleo-
phile is transferring the amino acid side chain, in approach II,
the amino acid side chain comes from the aldehyde incorporat-
ed in the imine.
Results and Discussion
Synthesis of propargylamines, general
strategies
To avoid side reactions of the terminal alkyne in approach I,
internal alkynes were applied. Benzoate substituents were
chosen as they are comparatively inert and convertible to
peptidomimetics. At first, iodobenzene derivatives with an ester
moiety in p- or m-position were reacted with propargyl alcohol
in a Sonogashira reaction to give the phenylpropargyl alcohols
1a and 1b (Figure 4) [42,43], which were transformed in a
Swern oxidation to afford the aldehydes 2a and 2b [44]. Con-
densation of the aldehydes 2a and 2b with (R)-configured tert-
butyl sulfinamide led to the enantiomerically pure sulfinylim-
ines 3a and 3b, which were reacted with a variety of organome-
tallic compounds, including iPrMgBr, MeMgBr and BnMgBr.
The reaction of the enantiomerically pure N-sulfinylimines 3a
and 3b with aliphatic organometallic nucleophiles resulted in
low yields and diastereoselectivity. The reaction of sulfinyl-
imine 3a with isopropylmagnesium bromide provided the
sulfinamide 4a in only 13% yield with a ratio of diastereomers
of 99:1. Only 10% of the addition product 4b were obtained by
addition of methylmagnesium bromide to the N-sulfinylimine
4b (dr 51:49). In order to prepare phenylalanine analogoues,
N-sulfinylimines 3a and 3b were reacted with benzylmagne-
sium bromide. However, only traces of the desired addition
products could be detected by LC–MS analysis of the crude
products.
Approach II starts with the condensation of an aldehyde with
Ellman’s chiral sulfinamide to provide a sulfinylimine [29-34],
which was reacted with (trimethylsilyl)ethynyllithium [1,14,45-
48]. The terminal TMS group was cleaved off after the addition
reaction [49,50] (Table 1).
Several conditions for the condensation of aldehydes with
Ellman’s chiral sulfinamide (S)-1 have been described. Cataly-
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Figure 4: Synthesis of propargylamines 4a and 4b by introducing the side chain as nucleophile. (a) HC≡CCH2OH, Cl2Pd(PPh3)2 (1 mol %), CuI
(2 mol %), THF/piperidine (3:1), rt, 2 h. (b) (COCl)2, DMSO, NEt3, −78 °C, DCM. (c) (R)-tert-Butyl sulfinamide ((R)-1), CuSO4, DCM, rt, 3 d (see
GP-2). (d) iPrMgBr, THF, −38 °C, AlMe3 in n-hexane (4a, 13%, dr 99:1). (e) MeLi in Et2O, toluene, −30 °C, AlMe3 in n-hexane (4b, 4%, dr 52:48).
(f) MeMgBr in Et2O, toluene, −35 °C (4b, 10%, dr 51:49).
Table 1: Preparation of N-sulfinyl propargylamines 7 with aliphatic side chains.a
R (a) Yield (5) (b), (c) Yield (7)b dr
Me GP-1c 81% (5a) GP-3, GP-5 47% (7a) 100:0
iPr GP-1 90% (5b) GP-3, GP-5 61% (7b) 97:3
CH2-iPr GP-1 92% (5c) GP-3, GP-5 53% (7c) 97:3
C6H11 GP-2 96% (5d) GP-3, GP-5 59% (7d) 97:3
t-Bu GP-2 18% (5e) GP-4, GP-5 41% (7e) 80:20
adamantyl GP-2 42% (5f) GP-4, GP-5 15% (7f) 100:0
CH2CH2SMe GP-2c 89% (5g) GP-4, GP-6 34% (7g)d 96:4
a(a) GP-1: Auxiliary (S)-1, aldehyde, Ti(OiPr)4, 70 °C, 40 min. GP-2: Auxiliary (S)-1, aldehyde, CuSO4, DCM, rt, 3 d. (b) GP-3: (Trimethylsilyl)ethynyl-
lithium, Ti(OiPr)4, THF, −78 °C to rt. GP-4: (Trimethylsilyl)ethynyllithium, AlMe3, toluene, −78 °C to rt. (c) GP-5: TBAF, THF, 0 °C, 3 h. GP-6: KF,
18-crown-6, THF/H2O (98:2), 0 °C. bIsolated yields are given, referring to 5 (over two steps (b) and (c)). cGP-1 had to be modified for the synthesis of
5a: acetaldehyde (5 equiv), MgSO4 (5 equiv), 30 °C, 12 h [51]. d(R)-configured Ellman’s sulfinamide (R)-1 was applied. Hence, the mirror images of
5–7g were obtained.
sis by Brønstedt acids has been reported [29], but was not
considered here due to the lability of the tert-butyl sulfinamide
moiety towards acids [1,25,26]. Strongly alkaline conditions
[30] were also avoided. Liquid aldehydes were readily
condensed with tert-butyl sulfinamide (S)-1 in the presence of
Ti(OEt)4 as Lewis acid and water scavenger [31-33]. However,
the removal of precipitated TiO2 was tedious and time
consuming. Therefore, dry CuSO4 as Lewis acid and water
scavenger at ambient temperature [34] represented a versatile
method, leading to high yields of sulfinylimines 5. (Trimethyl-
silyl)ethynylmagnesium bromide has already been successfully
added to sulfinylimines to produce various N-sulfinyl
propargylamines in excellent yields and diastereomeric excesses
[13,16]. Several N-sulfinyl propargylamines (analogoues of
valine, phenylglycine and tyrosine) have been prepared using a
large excess (4 equivalents) of [(trimethylsilyl)ethynyl]di-
methylaluminum as the nucleophile [14,48,52]. The reaction of
the sulfinylimines 5 with (trimethylsilyl)ethynyllithium provi-
Beilstein J. Org. Chem. 2017, 13, 2428–2441.
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Figure 5: Reaction of N-sulfinylimine 5h with (trimethylsilyl)ethynyllithium. (a) GP-3 or GP-4. (b) Aqueous work-up, H2O/H+. Deprotonation in benzylic
position competes with nucleophilic attack (5h/6h, 7:3).
ded the crude intermediates 6, which were converted into the
N-sulfinyl propargylamines 7 in high yields and satisfactory
diastereomeric ratios by cleaving off the TMS protecting group
with TBAF. In previous investigations, the choice of solvent
and Lewis acid were controversially discussed [13,14,45-50,52-
55]. Nonpolar solvents (DCM < THF < Et2O < toluene) have
been described to enhance the stability of the transition state,
improving the diastereomeric ratio, as well as the reactivity of
the nucleophile, resulting in an improved yield [45]. As
aldimines have been reported to be rather unreactive electro-
philes [53], hard Lewis acids (AlMe3 > AlR3 > Ti(OiPr)4 [14] >
BF3 > MgBr2 > ZnCl2 > ZnEt2) have been recommended for
activation [45]. However, the Lewis acid BF3 was shown to
give products with inverted configuration of the newly formed
chiral center [47]. While several authors obtained increased
yields upon addition of AlMe3 [1,45,46], others advised against
its use as activation agent of aldimines, because side reactions
were observed [13,54,55], which will also be further discussed
below. We used THF or toluene as solvents and AlMe3 or
Ti(OiPr)4 as activation agent. According to Ellman et al., the
diastereoselectivity of the addition to sulfinylimines is con-
trolled by the formation of a cyclic, six-membered, chair-like
transition state, which is formed by precoordination of the
organometallic reagent to aldimine 5 [45]. This cyclic transi-
tion state accounts for the preferred re-face attack of the nucleo-
phile at (S)-configured N-sulfinylimines, which leads to amines
with the same configuration as the proteinogenic (S)-config-
ured amino acids. This stereoselection was confirmed by
various X-ray crystal structures of propargylamines obtained
during our investigations like 7a, 7c–e, 7s, 7i–k, 7q and tri-
azole 13w (see Supporting Information File 1). Independent on
the substituent, solvent and Lewis acid used, the direction of the
nucleophilic attack of (trimethylsilyl)ethynyllithium was always
the same, forming the new centers of chirality of all N-sulfinyl
propargylamines 7 configured as expected. As already de-
scribed by Ellman et al. [45], the size of the side chain corre-
lates with the result of the reaction. The diastereomeric excesses
increased in a size-dependent manner in the order 6a (alanine) <
6c (leucine) < 6d (cyclohexylglycine) (compare Table 1). The
yield of the tert-leucine derivative 6e was reduced due to steri-
cally shielding of the imino moiety by the tert-butyl group.
The cleavage of the TMS groups of the addition products 6
could be accomplished with TBAF in THF [49,50,56]. Basic
conditions, like K2CO3 as described in the literature [50,57] did
not lead to the desired N-sulfinyl propargylamines 7. We
assume that strong bases do not only lead to desilylation, but
also induce decomposition of the propargylamine system
(see below). Kracker et al. recently demonstrated the substitu-
tion of the labile tert-butylsulfinyl group of compounds 7a–c by
the more versatile Boc protective group in yields of 56–94%
[21].
Synthesis of propargylamines containing
electron-withdrawing substituents
Aromatic and carbonyl substituents in the Cβ-position of
propargylamines (occurring in analogoues of the amino acids
phenylalanine, tyrosine, histidine, tryptophan, aspartic acid and
asparagine) increase the acidity of the adjacent protons consid-
erably. In the precursor sulfinylimines 5 of the target propargyl-
amines the acidity of the protons of the methylene moiety is
further increased by the electron-withdrawing effect of the adja-
cent sulfinyl imino moiety. Thus, the nucleophilic addition of
(trimethylsilyl)ethynyllithium is competing with deprotonation
of the methylene moiety giving rise to the formation of the
azaenolate (Figure 5). The resulting anion is reprotonated
during aqueous work-up, leading to the starting sulfinylimine 5.
Benzyl-substituted N-sulfinyl propargylamine 6h was prepared
by the addition of (trimethylsilyl)ethynyllithium to N-sulfinyl-
imine 5h. The starting material 5h and the addition product 6h
were isolated in a 7:3 ratio indicating deprotonation to be the
predominant reaction. The phenylalanine analogous N-sulfinyl
propargylamine 7h was isolated in only 12% yield (over two
steps, referring to imine 5h) after desilylation with TBAF
(Table 2). As the benzylic proton of sulfinylimine 5h is quite
acidic, approach II was not pursued for the synthesis of
propargylamines analogous to tyrosine, histidine, tryptophan,
and aspartate.
Proteinogenic amino acids do not contain substituents, which
additionally increase the acidity of the α-proton. Nevertheless,
glycine derivatives with electron-withdrawing substituents like
Beilstein J. Org. Chem. 2017, 13, 2428–2441.
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Table 2: Synthesis of propargylamines 7 with electron-withdrawing substituents in the side chain.a
R (a) Yield (5) (b) Yield (6) (c) Yield (7) dr
CH2Ph GP-2 64% (5h) GP-4 34% (6h) GP-5 35% (7h) 97:3
Ph GP-1 99% (5i) GP-4 54% (6i) GP-7 66% (7i) 95:5
C6F5 GP-2 88% (5j) GP-4 41% (6j) GP-6 52% (7j) 100:0
CF3 GP-2b n.i. (5k) GP-4 33%c (6k) GP-6 29% (7k) 93:7
CCl3 GP-2b 87% (5l) GP-4 10% (6l) GP-6 57% (7l) 100:0
a(a) GP-1: Auxiliary (S)-1, aldehyde, Ti(OiPr)4, 70 °C, 40 min. GP-2: Auxiliary (S)-1, aldehyde, CuSO4, DCM, rt, 3 d. (b) GP-4: (Trimethylsilyl)ethynyl-
lithium, AlMe3, toluene, −78 °C to rt. (c) GP-5: TBAF, THF, 0 °C, 3 h. GP-6: KF, 18-crown-6, THF/H2O (98:2), 0 °C. GP-7: 1. AgNO3, EtOH, 0 °C;
2. KCN, EtOH, HCl. bFor the synthesis of 5k, procedure GP-2 was modified: The aldehyde was distilled under argon atmosphere, condensed onto a
mixture of sulfinamide (S)-1 and molecular sieves 4 Å. Toluene was added and the solution was stirred for 48 h. 5k was directly applied for subse-
quent reactions and could not be isolated (n.i.). cYield refers to Ellman’s chiral sulfinamide (S)-1.
formylglycine [58,59], phenylglycine [60,61] and fluorinated
alanine [62-64] have attracted great attention as peptido-
mimetics, drugs or in the bioorthogonal functionalization of
larger peptides.
The trifluoromethyl moiety has been reported to enhance the ac-
tivity, stability and selectivity of various pharmacologically
active compounds [65,66], e.g., trifluridine [67-70], efavirenz
[71-73], fluoxetine [74-76] and fluozolate [77]. As the general
structure of fluorinated propargylamines occurs in important
drugs, like HIV protease inhibitor DPC 961 and its analogues
[78-83], particular effort was put on the synthesis of N-sulfinyl
propargylamine 7k. Because of the poor electrophilicity of
imines 5, the nucleophilic addition of trifluoromethyl nucleo-
philes, such as TMS–CF3 [84,85] has been described to be inef-
ficient. Still, the asymmetric synthesis of CF3-substituted
propargylamines has been described, using (R)-2-methoxy-1-
phenylethan-1-amine as chiral auxiliary [86-88]. However,
cleavage of the protective group requires reductive conditions,
which also affects the CF3 group and the alkyne [86-88].
Various trifluoromethyl-substituted ketones have been con-
verted into N-sulfinylimines, which were subsequently trans-
formed into sulfinamides attached to a tertiary C-atom by
addition of nucleophiles [89-92]. N-Sulfinyl propargylamine 7k
was prepared, following approach II under varying conditions
(Table 2). Fluoral hydrate was dehydrated with concentrated
sulfuric acid to give trifluoroacetaldehyde by distillation [93].
The reaction of trifluoroacetaldehyde with tert-butyl sulfin-
amide (S)-1 in the presence of molecular sieves 4 Å provided
the sulfinylimine 5k, which could not be isolated due to its
extremely high electrophilicity. Instead, immediate hydrolysis
occurs upon contact with water forming hemiaminal 8k
(Figure 6), as already observed by Truong et al. [94]. This
frequently observed hemiaminal was isolated by column chro-
matography and recrystallized from EtOAc.
Distillation of imine 5k has been reported to provide a very low
yield (22% [94]). The reaction of hemiaminal 8k with (tri-
methylsilyl)ethynyllithium in the presence of the strong Lewis
acid AlMe3 has been proposed by Truong et al. [94], but was re-
ported to give very poor yields and low diastereoselectivity. In
contrast to the argumentation of Xiao et al., who strongly
recommended hard Lewis acids for the reaction of sulfinylim-
ines with various ethynyllithium reagents [95], the crude imine
5k predominantly reacted with the Lewis acids Ti(OiPr)4 and
AlMe3 and gave only low yields of the desired N-sulfinyl
propargylamine 6k. The reaction of crude 5k in the presence of
the Lewis acid Ti(OiPr)4 afforded the N/O-acetal 9k, whereas
the attempt of activation with AlMe3 provided the methylated
sulfinamide 10k. Both side products were isolated as colorless
crystalline solids. It is assumed, that the undesired side prod-
ucts 9k and 10k were formed by a ligand transfer from the
Lewis acids to imine 5k. Nucleophilic substitution of N/O-
acetal 9k with two equivalents of (trimethylsilyl)ethynyllithium,
in analogy to the conversions reported by Kuduk et al. [96],
remained unsuccessful. The (S)-configuration of the newly
generated chiral center of amine 10k was determined by X-ray
structure analysis (Figure 7), suggesting two possible transition
states for the ligand transfer.
Whereas transition state TII requires only one equivalent of
AlMe3, two equivalents of AlMe3 are involved in transition
Beilstein J. Org. Chem. 2017, 13, 2428–2441.
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Figure 6: Side reactions observed in the course of the conversion of highly electrophilic sulfinylimines 5. (a) Sulfinamide (S)-1, molecular sieves 4 Å,
toluene. (b) 1. Dilution with H2O, 2. Extraction with DCM. (c) Addition of Ti(OiPr)4 prior to the conversion with (trimethylslyl)ethynyllithium [94]. (d) Ad-
dition of AlMe3 prior to the conversion with (trimethylsilyl)ethynyllithium.
Figure 7: a) Possible transition states TI and TII for the transfer of the methyl moiety from AlMe3 to the imino moiety. b) X-ray crystal structure analy-
sis of the methyl transfer product 10k.
state TI. As in this case almost quantitative conversion of
AlMe3 was observed, transition state TII seems to be more
probable. Still, more complex coordination geometry (hexago-
nal or dinuclear complexes) of the Lewis acid are probable as
well and hardly depend on the stoichiometry. In the conversion
of highly reactive sulfinylimines like 5k, best results were ob-
tained in the absence of a Lewis acid. Analogous investigations
with chloral hydrate instead of fluoral hydrate showed that the
trichloromethylimine 5l also forms a hemiaminal 8l upon con-
tact with water, but does not undergo comparable side reactions
with Ti(OiPr)4 or AlMe3. Sulfinylimine 5l appears to be a
weaker electrophile, which is attributed to the lower electroneg-
ativity of Cl compared to F and to the larger size of the CCl3
group compared to the CF3 moiety, sterically shielding imine 5
against nucleophilic attack.
Desilylation of N-sulfinyl propargylamine 6i with TBAF (GP-5)
resulted in decomposition instead of formation of the free
alkyne 7i. In order to obtain the free terminal alkyne 7i, a milder
desilylation procedure was required. Therefore, AgNO3 and
KCN (GP-7) were used for the desilylation of 6i to afford the
free alkyne 7i in 66% yield. N-Sulfinyl propargylamines 6k and
6j, with perfluorinated side chains, required even milder desilyl-
ation conditions. KF in the presence of 18-crown-6 (GP-6) pro-
vided the free alkynes 7k and 7j in 29% and 52% yield, respec-
tively (results are collected in Table 2).
Desilylation of alkynes 6k and 6j under alkaline conditions with
K2CO3, in analogy to the description of Vasella et al. [57] leads
to instant decomposition of the starting material in a base-
promoted propargyl–allenamide isomerization. According to
our hypothesis, basic fluoride leads to deprotonation in the
Cα-position of 6i, 6k and 6j, inducing an alkyne rearrangement
to form an allene, which rearranges further to provide an α,β-
unsaturated imine (Figure 8) [97].
One target application of propargylamines 7 is the Sonogashira
cross-coupling with halogenated benzoates, forming the scaf-
Beilstein J. Org. Chem. 2017, 13, 2428–2441.
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Figure 8: Base-induced rearrangement of propargylamines bearing electron-withdrawing substituents.
Figure 9: Base-catalyzed rearrangement of propargylamines 11 to α,β-unsaturated imines 12. A) Reaction scheme: (a) methyl 4-iodobenzoate (for
the conversion of 7i to 11i, 1.6 equiv) or methyl 3-iodobenzoate (for the conversion of 7k to 11k), DIPEA (6 equiv), THF, Cl2Pd(PPh3)2, CuI, room
temperature, 2 h (GP-9). (b) Piperidine/THF (1:3), 0 °C, 30 min (conversion of 11i to 12i). Or LiOH (3 equiv), MeOH/H2O (2:1), 0 °C, 30 min.
B) UV–vis spectra of propargylamines 11 and α,β-unsaturated imines 12. C) X-ray crystal structure analysis of propargylamine 11i and α,β-unsatu-
rated imine 12i.
fold of versatile peptidomimetics 11. According to the pro-
posed rearrangement of alkyne 7 (Figure 9), the choice of base
is crucial for such cross-coupling reactions. To get a better
understanding of the reactivity of propargylamines, the stability
and propensity for base induced rearrangement of 11 were in-
vestigated (Figure 9).
Beilstein J. Org. Chem. 2017, 13, 2428–2441.
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Table 3: Preparation of N-sulfinyl propargylamines 7 with polar and acidic functional groups in the side chains.a
R (a) Yield (5) (b), (c) Yield (7)b dr
CH2OCPh3 GP-2 47% (5m) GP-4, GP-6 0% (7m)c n.d.
CH2OBn GP-2 81% (5n)d GP-3, GP-5 4% (7n)e 95/5
CH2OAll GP-1 24% (5o) GP-4, GP-5 31% (7o) 93/7
CH2SBn GP-2 83% (5p)d GP-3, GP-5 31% (7p)f 93/7
(CH2)3CN GP-2 80% (5q) GP-4, GP-6 43% (7q) 95/5
(CH2)2CO2Bn GP-2 79% (5r) GP-4, GP-5 0% (7r)c n.d.
(CH2)2CO2t-Bu GP-2 64% (5s) GP-4, GP-6 47% (7s) 93/7
(CH2)3OXf GP-1 90% (5t) GP-3, GP-5 27% (7t) 93/7
(CH2)3Cl GP-1 85% (5u) GP-4, GP-5 0% (7u)c n.d.
(CH2)4N3 GP-2 52% (5v) f
(CH2)3N3 GP-2 84% (5w) f
a(a) GP-1: Auxiliary (S)-1, aldehyde, Ti(OiPr)4, 70 °C, 40 min. GP-2: Auxiliary (S)-1, aldehyde, CuSO4, DCM, rt, 3 d. (b) GP-4: (Trimethylsilyl)ethynyl-
lithium, AlMe3, toluene, −78 °C to rt. (c) GP-5: TBAF, THF, 0 °C, 3 h. GP-6: KF, 18-crown-6, THF/H2O (98:2), 0 °C. bYields of 7 refer to imine 5 (two
steps). cCompounds 7m, 7r and 7u could not be isolated and the diastereoselectivity could not be determined (n.d.). dFurther reactions in Table 4.
e(R)-Configured Ellman’s sulfinamide (R)-1 was applied. Hence, the mirror images of 5–7n,p were obtained. f5t, X = TBDMS. 7t, X = H.
The ester substituted compounds 11i and 11k were obtained by
Sonogashira cross-coupling of the terminal alkynes 7i and 7k
with methyl 4- and 3-iodobenzoate, respectively. As the tert-
butylsulfinyl group can be cleaved off under mild, acidic condi-
tions [1,25,26], it provides a versatile protective group for the
amine during the conversion of the alkyne. Additionally, it’s
chirality indicates epimerization and, for example in the
Pauson–Khand reaction [14], allows the determination of the
stereoselectivity of asymmetric conversions by simple 1H NMR
experiments. Consequently it was not removed prior to the rear-
rangement experiments.
Treatment of 11i and 11k with the mild base piperidine led to
the formation of α,β-unsaturated sulfinylimines 12i and 12k.
The structures of the rearranged products were proven unequiv-
ocally by 1H and 13C NMR spectroscopy and X-ray crystal
structure analysis.
Due to the extended π-system of the α,β-unsaturated imines 12i
and 12k, the progress of the propargylamide–allenylamide rear-
rangement that eventually leads to the formation of the α,β-
unsaturated imines by tautomerism could be easily monitored
by UV–vis spectroscopy. The reaction mixture turned brightly
yellow when treated with bases like piperidine. The X-ray
crystal structures of 11i and 12i confirm unequivocally the
structure of the products and thus the postulated two-step rear-
rangement. Both, the rearrangement of the alkyne to the allene
and the subsequent tautomerism to the α,β-unsaturated imine
are not reversible. Reversibility of the rearrangement would be
fundamental for racemization of propargylamines, which is
consequently improbable. However, even in the presence of
strong bases like KOt-Bu or LDA, the propargylamide–allenyl-
amide rearrangement could never be observed for propargyl-
amines without an acidifying Cα-substituent.
Synthesis of propargylamines containing
polar or acidic functional groups
The synthesis of propargylamines with polar substituents to
mimic polar amino acids such as serine (alcohol), cysteine
(thiol) or glutamine (carboxamide) requires special protective
groups (Table 3).
The cyano moiety was used as precursor of the carboxamide
moiety of glutamine, since the cyano group is stable in the pres-
ence of nucleophiles and strong bases. The synthesis started
with the Kolbe nitrile synthesis of 4-iodobutan-1-ol with NaCN.
Performing this transformation in DMSO provided the desired
5-hydroxypentanenitrile and THF in the ratio 5:2 (monitored by
1H NMR spectroscopy, see Supporting Information File 1).
Next, 4-cyanobutan-1-ol was oxidized in a Swern oxidation and
the resulting aldehyde was condensed with tert-butylsulfi-
namide (S)-1, according to GP-2. The reaction of sulfinimine 5q
with (trimethylsilyl)ethynyllithium led to sulfinamide 6q. In this
case, the Lewis acid AlMe3, which could also react with the
cyano moiety, was omitted. Finally, cleavage of the TMS group
was achieved under mild conditions with KF and 18-crown-6
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(GP-6), to yield N-sulfinyl propargylamine 7q as an analogue of
the non-proteinogenic amino acid 5-cyano-L-norvaline. Forma-
tion of a glutamine analogous side chain by hydrolysis of the
nitrile function to an amide remained unsuccessful so far.
Propargylamines with diversely protected alcohol functionali-
ties in the side chain were obtained by approach II. The applica-
tion of an allyl ether, starting from 2-allyloxyacetaldehyde to
form 7o and a benzoate, starting from formylmethyl benzoate to
form 7n (Table 3) turned out to be most convenient. In contrast
to labile TMS ethers, the sterically more demanding tert-butyl
dimethylsilyl ether was successfully applied as protective group
to obtain the homologated serine analogous propargylamine 7t
similar to the description by Verrier et al. [47,55], starting from
TBDMS-protected oxybutanal. Treatment of alkyne 6t with
TBAF leads to simultaneous cleavage of both silyl groups. Al-
though sterically shielding protective groups have proven con-
venient, the trityl group turned out to be inefficient to generate a
serine-analogous propargylamine. Trityl-protected imine 5m
immediately decomposed, when treated with (trimethyl-
silyl)ethynyllithium.
The preparation of glutamic acid-analogous propargylamines
failed when the acid functionality was protected as a benzyl
ester. Fortunately, the sterically more demanding tert-butyl
ester was stable and gave high yields of 7s. The synthesis
started from the aldehyde tert-butyl-4-oxobutanoate, which
could be easily obtained from succinic anhydride [44,98,99].
Selective cleavage of the tert-butyl group was not yet accom-
plished without affecting the tert-butyl sulfinamide protection
group of the amine.
A cysteine-analogous alkyne could be synthesized starting from
benzylmercaptan. Unfortunately, only extremely low yields
were achieved and N-sulfinyl propargylamine 7p is not stable
under the conditions, which are necessary to cleave the
thioether [100,101].
Synthesis of propargylamines with basic
functional groups in the side chain
Very often, basic amino acids, like lysine or arginine are found
in the catalytic center of enzymes. Therefore, propargylamines
mimicking these basic amino acids are of particular interest to
be incorporated in peptidomimetics. The exchange of basic
amino acids has already been performed to develop potent en-
zyme inhibitors [102-104]. In order to introduce side chains
with basic amino moieties into propargylamines, these have to
be protected against nucleophiles, bases and deprotonation.
According to the approach of Ye et al., a 3-bromopropyl side
chain was used, which was converted to the azide and further
transformed into an aminoalkyl group by Staudinger reduction
[16]. In order to follow a more convergent approach and to
avoid nucleophilic substitution of the halide at a late stage, we
decided to start the synthesis with 4-azidobutanal, which was
prepared by opening THF with iodine and NaBH4, nucleophilic
substitution by sodium azide and Swern oxidation of the
alcohol.
4-Azidobutanal was converted with chiral sulfinamide (S)-1
into N-sulfinylimine 5w, which was reacted with (trimethyl-
silyl)ethynyllithium. However, following the usual procedure
GP-4 with warming up the reaction mixture to room tempera-
ture before quenching with water led to the formation of tri-
azole 13w, which was isolated in 56% yield (Table 4). The
target propargylamine 6wx was obtained in only 19% yield.
Cleavage of the TMS group with KF and 18-crown-6 at 0 °C
provided azide 7wx in only 22% yield, because triazole 14w
was formed in a side reaction. Compound 7wx was converted
into triazole 14w even upon standing at room temperature in
CDCl3 (monitored by 
1H NMR spectroscopy, see Supporting
Information File 1). Formation of triazoles 13w and 14w was
unexpected, because the uncatalyzed Huisgen reaction usually
requires higher temperature or activation by electron-with-
drawing substituents at the alkyne or electron-donating substitu-
ents at the azide, respectively [105,106]. As none of these
requirements are met in the case of 6wx and 7wx, it is assumed,
that the preorientation of the azide and the alkyne together with
the formation of an energetically favored six-membered ring are
the driving forces. As hexose scaffolds similar to 13w and 14w
have been successfully applied as inhibitors of β-glucosidases
[107] and hexosamidases [108], this intramolecular Huisgen
reaction could be exploited to develop novel enzyme inhibitors.
In order to get access to propargylamines with the side chains of
lysine, ornithine and arginine, azide 7wx should be reduced.
However, all attempts to reduce the isolated azide 7wx with
NaBH4 or PPh3 failed, due to the competing triazole formation.
Therefore, instant reduction of in situ prepared 6wy was envis-
aged. The nucleophilic addition of (trimethylsilyl)ethynyl-
lithium to N-sulfinylimine 5w was monitored by analytical
HPLC. After complete conversion, PPh3 was added directly to
the reaction mixture at −78 °C. After addition of water and stir-
ring for two hours, the primary amine 7wy was isolated in 86%
yield. This procedure led to the ornithine analogous propargyl-
amine 7wy ,  which was reacted with Boc-protected
S-methylisothiourea to yield the arginine analogous propargyl-
amine 7x in a yield of 79%. During the decomposition of the
azide in the Staudinger reaction, the TMS group at the alkyne
was cleaved off simultaneously. Cleavage of TMS groups with
PPh3 under similar conditions has not been reported so far.
Therefore, an intramolecular mechanism is postulated, in which
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Table 4: Synthesis of lysine, ornithine and arginine-analogous propargylamines 7vy, 7wy and 7x and discovery of an unexpected intramolecular low-
temperature Huisgen reaction.
Starting
material
Reaction conditions Product Yield dr
5v (a) (trimethylsilyl)ethynyllithium, Ti(OiPr)4, THF, −78 °C (GP-3) 6v 58% 100:0
5w (a) (trimethylsilyl)ethynyllithium, Ti(OiPr)4, THF, −78 °C. (GP-3) 6w 14% n.d.
6v (b) (trimethylsilyl)ethynyllithium, AlMe3, toluene, −78 °C (GP-4) 13w 56% 100:0
6v (c) TBAF (2 equiv), THF, 0 °C, 4 h (GP-5) 7vx 58% 74:26
6w (c) TBAF (2 equiv), THF, 0 °C, 4 h (GP-5) 7wx 19% 96:4
7wx (d) CDCl3, 7 d, rt. 14w 66% 96:4
7vx (e) 1. PPh3, CuSO4, THF; 2. H2O. 7vy 0% n.d.
7wx (e) 1. PPh3, CuSO4, THF; 2. H2O. 7wy 0% n.d.
6v (f) 1. NaBH4, CuSO4, THF; 2. H2O. 7vy 0% n.d.
6w (f) 1. NaBH4, CuSO4, THF; 2. H2O. 7wy 0% n.d.
5v (g) 1. (trimethylsilyl)ethynyllithium, toluene, −78 °C, 3 h; 2. PPh3
(4 equiv), THF, −78 °C; 3. H2O, rt, 2 h.
7vy 68% 91:9
5w (g) 1. (trimethylsilyl)ethynyllithium, toluene, −78 °C, 3 h; 2. PPh3
(4 equiv), THF, −78 °C; 3. H2O, rt, 2 h.
7wy 86% 80:20
7vy (h) 1. Boc2O (2 equiv), THF/H2O (1:1), NaHCO3 (3 equiv);
2. imidazole, 4 h.
7vz 45% 91:9
7wy (h) 1. Boc2O (2 equiv), THF/H2O (1:1), NaHCO3 (3 equiv);
2. imidazole, 4 h.
7wz 63% 90:10
7wy (i) BocHN-C(=NBoc)SMe (1 equiv), DCM, rt, 3 d. 7x 79% 93:7
the iminophosphorane, formed by the reaction of PPh3 with
azide 6wy, coordinates to the silyl group. This intramolecular
coordination facilitates the fast hydrolytic cleavage of the silyl
group during aqueous work-up. This PPh3-induced TMS
cleavage could also be successfully applied in the synthesis of
the lysine analogous propargylamine 7vy from 5v but could
never be reproduced in the formation of other propargylamines,
like the tert-butyl-substituted compound 7e, under identical
reaction conditions. The amine groups of 7wy and 7vy were
protected with a Boc group to give propargylamines 7wz and
7vz.
Conclusion
Ellman’s chiral sulfinamide has been successfully used for the
asymmetric synthesis of enantiomerically pure propargyl-
amines. An array of 24 diastereomerically pure N-sulfinyl
propargylamines has been prepared, bearing side chains in
α-position, which are analogous or similar to amino acid side
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chains. In general, various aldehydes are condensed with
Ellman’s chiral sulfinamide. Diastereoselective re-face addition
of (trimethylsilyl)ethynyllithium to the (S)-configured sulfin-
imines 5 gives the corresponding N-sulfinyl propargylamines 6.
Cleavage of the TMS group with TBAF or KF × 18-crown-6
provides N-sulfinyl propargylamines 7 with a terminal alkyne.
Propargylamines with aliphatic side chains were obtained in
good yields, depending on the size of the Cα substituent.
Various polar and basic substituents in the side chain can be
introduced using masked or protected functionalities. Side
chains with amino groups were introduced masked as azide. For
this purpose, the unprecedented intramolecular Huisgen reac-
tion has to be suppressed. Electron-withdrawing substituents in
the Cβ-position could not be used by this approach. Electron-
withdrawing substituents in the Cα-position induced an irre-
versible alkyne–allene-α,β-unsaturated imine rearrangement
under mild basic conditions, which makes an alkaline racemiza-
tion of propargylamines improbable. Altogether, a large set of
propargylamines with various amino acid similar substituents
are available for application in peptidomimetics and some
knowledge on the reactivity of propargylamines has been con-
tributed.
Supporting Information
Supporting Information File 1
Details about the experiments, methods and materials, the
X-ray crystal structures and NMR spectra.
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